These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 37315342)
1. Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Synthesis, biochemistry, and molecular dynamics study. Thomas Parambi DG; Oh JM; Kumar S; Sudevan ST; Hendawy OM; Abdelgawad MA; Musa A; Al-Sanea MM; Ahmad I; Patel H; Kim H; Mathew B Comput Biol Chem; 2023 Aug; 105():107899. PubMed ID: 37315342 [TBL] [Abstract][Full Text] [Related]
2. Introduction of benzyloxy pharmacophore into aryl/heteroaryl chalcone motifs as a new class of monoamine oxidase B inhibitors. Sudevan ST; Oh JM; Abdelgawad MA; Abourehab MAS; Rangarajan TM; Kumar S; Ahmad I; Patel H; Kim H; Mathew B Sci Rep; 2022 Dec; 12(1):22404. PubMed ID: 36575270 [TBL] [Abstract][Full Text] [Related]
3. The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor. Zarmouh NO; Eyunni SK; Soliman KF BMC Complement Altern Med; 2017 Jan; 17(1):34. PubMed ID: 28069007 [TBL] [Abstract][Full Text] [Related]
4. Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer's Disease. Reeta ; Baek SC; Lee JP; Rangarajan TM; Ayushee ; Singh RP; Singh M; Mangiatordi GF; Nicolotti O; Kim H; Mathew B CNS Neurol Disord Drug Targets; 2019; 18(8):643-654. PubMed ID: 31550216 [TBL] [Abstract][Full Text] [Related]
5. Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action. Elkamhawy A; Kim HJ; Elsherbeny MH; Paik S; Park JH; Gotina L; Abdellattif MH; Gouda NA; Cho J; Lee K; Nim Pae A; Park KD; Roh EJ Bioorg Chem; 2021 Nov; 116():105352. PubMed ID: 34562673 [TBL] [Abstract][Full Text] [Related]
6. Calycosin and 8-O-methylretusin isolated from Maackia amurensis as potent and selective reversible inhibitors of human monoamine oxidase-B. Oh JM; Jang HJ; Kim WJ; Kang MG; Baek SC; Lee JP; Park D; Oh SR; Kim H Int J Biol Macromol; 2020 May; 151():441-448. PubMed ID: 32087226 [TBL] [Abstract][Full Text] [Related]
7. Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies. Elkamhawy A; Paik S; Park JH; Kim HJ; Hassan AHE; Lee K; Park KD; Roh EJ Bioorg Chem; 2021 Oct; 115():105233. PubMed ID: 34390968 [TBL] [Abstract][Full Text] [Related]
8. Potent and selective inhibition of human monoamine oxidase-B by 4-dimethylaminochalcone and selected chalcone derivatives. Oh JM; Kang MG; Hong A; Park JE; Kim SH; Lee JP; Baek SC; Park D; Nam SJ; Cho ML; Kim H Int J Biol Macromol; 2019 Sep; 137():426-432. PubMed ID: 31271801 [TBL] [Abstract][Full Text] [Related]
9. Medicarpin and Homopterocarpin Isolated from Oh JM; Jang HJ; Kang MG; Mun SK; Park D; Hong SJ; Kim MH; Kim SY; Yee ST; Kim H Molecules; 2022 Dec; 28(1):. PubMed ID: 36615451 [TBL] [Abstract][Full Text] [Related]
10. Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity. Baek SC; Kang MG; Park JE; Lee JP; Lee H; Ryu HW; Park CM; Park D; Cho ML; Oh SR; Kim H Bioorg Med Chem Lett; 2019 Mar; 29(6):839-843. PubMed ID: 30686752 [TBL] [Abstract][Full Text] [Related]
11. Development of methylthiosemicarbazones as new reversible monoamine oxidase-B inhibitors for the treatment of Parkinson's disease. Mathew GE; Oh JM; Mohan K; Tengli A; Mathew B; Kim H J Biomol Struct Dyn; 2021 Aug; 39(13):4786-4794. PubMed ID: 32588753 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Monoamine Oxidases by Pyridazinobenzylpiperidine Derivatives. Oh JM; Zenni YN; Özdemir Z; Kumar S; Kılıç S; Akdağ M; Özçelik AB; Kim H; Mathew B Molecules; 2024 Jun; 29(13):. PubMed ID: 38999047 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel 3,4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the neuroprotection against Parkinson's disease. Liu L; Chen Y; Zeng RF; Liu Y; Xie SS; Lan JS; Ding Y; Yang YT; Yang J; Zhang T Bioorg Chem; 2021 Apr; 109():104685. PubMed ID: 33640631 [TBL] [Abstract][Full Text] [Related]
15. Development of Halogenated Pyrazolines as Selective Monoamine Oxidase-B Inhibitors: Deciphering via Molecular Dynamics Approach. Nair AS; Oh JM; Koyiparambath VP; Kumar S; Sudevan ST; Soremekun O; Soliman ME; Khames A; Abdelgawad MA; Pappachen LK; Mathew B; Kim H Molecules; 2021 May; 26(11):. PubMed ID: 34071665 [TBL] [Abstract][Full Text] [Related]
16. Exploration of chlorinated thienyl chalcones: A new class of monoamine oxidase-B inhibitors. Mathew B; Haridas A; Uçar G; Baysal I; Adeniyi AA; Soliman ME; Joy M; Mathew GE; Lakshmanan B; Jayaprakash V Int J Biol Macromol; 2016 Oct; 91():680-95. PubMed ID: 27262516 [TBL] [Abstract][Full Text] [Related]
17. Exploration of Umbelliferone Based Derivatives as Potent MAO Inhibitors: Dry vs. Wet Lab Evaluation. Dhiman P; Malik N; Khatkar A Curr Top Med Chem; 2018; 18(21):1857-1871. PubMed ID: 30430943 [TBL] [Abstract][Full Text] [Related]
18. Identification of Indole-Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO-B Inhibitors. Sasidharan R; Manju SL; Uçar G; Baysal I; Mathew B Arch Pharm (Weinheim); 2016 Aug; 349(8):627-37. PubMed ID: 27373997 [TBL] [Abstract][Full Text] [Related]
19. Biphenylpiperazine Based MAO Inhibitors: Synthesis, Biological Evaluation, Reversibility and Molecular Modeling Studies. El-Halaby LO; El-Husseiny WM; El-Messery SM; Goda FE Bioorg Chem; 2021 Oct; 115():105216. PubMed ID: 34352710 [TBL] [Abstract][Full Text] [Related]